Schonfeld Strategic Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-158
| Closed | -$60K | – | 1860 |
|
|
2020
Q4 | $60K | Buy |
+158
| New | +$60K | ﹤0.01% | 1450 |
|
|
2018
Q3 | – | Sell |
-1,400
| Closed | -$2.26M | – | 861 |
|
|
2018
Q2 | $2.26M | Sell |
1,400
-996
| -42% | -$1.61M | 0.12% | 249 |
|
|
2018
Q1 | $3.89M | Sell |
2,396
-2,104
| -47% | -$3.42M | 0.29% | 99 |
|
|
2017
Q4 | $7.56M | Sell |
4,500
-501
| -10% | -$841K | 0.62% | 29 |
|
|
2017
Q3 | $7M | Sell |
5,001
-409
| -8% | -$572K | 0.64% | 33 |
|
|
2017
Q2 | $6.04M | Buy |
+5,410
| New | +$6.04M | 0.62% | 31 |
|